These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23386789)
1. Metabolic biomarkers for predicting cardiovascular disease. Montgomery JE; Brown JR Vasc Health Risk Manag; 2013; 9():37-45. PubMed ID: 23386789 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers as a guide of medical treatment in cardiovascular diseases. Vavuranakis M; Kariori MG; Kalogeras KI; Vrachatis DA; Moldovan C; Tousoulis D; Stefanadis C Curr Med Chem; 2012; 19(16):2485-96. PubMed ID: 22489719 [TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Development of Cardiovascular Biomarkers. Satoh K; Shimokawa H Arterioscler Thromb Vasc Biol; 2018 May; 38(5):e61-e70. PubMed ID: 29695533 [No Abstract] [Full Text] [Related]
4. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin. May A; Wang TJ Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909 [TBL] [Abstract][Full Text] [Related]
5. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Torres JL; Ridker PM Curr Opin Cardiol; 2003 Nov; 18(6):471-8. PubMed ID: 14597888 [TBL] [Abstract][Full Text] [Related]
8. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Vlachopoulos C; Xaplanteris P; Aboyans V; Brodmann M; Cífková R; Cosentino F; De Carlo M; Gallino A; Landmesser U; Laurent S; Lekakis J; Mikhailidis DP; Naka KK; Protogerou AD; Rizzoni D; Schmidt-Trucksäss A; Van Bortel L; Weber T; Yamashina A; Zimlichman R; Boutouyrie P; Cockcroft J; O'Rourke M; Park JB; Schillaci G; Sillesen H; Townsend RR Atherosclerosis; 2015 Aug; 241(2):507-32. PubMed ID: 26117398 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. Nead KT; Zhou MJ; Caceres RD; Sharp SJ; Wehner MR; Olin JW; Cooke JP; Leeper NJ Am J Cardiol; 2013 Mar; 111(6):851-6. PubMed ID: 23290308 [TBL] [Abstract][Full Text] [Related]
11. Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases. Jansen F; Li Q Adv Exp Med Biol; 2017; 998():61-70. PubMed ID: 28936732 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Ridker PM Clin Chem; 2009 Feb; 55(2):209-15. PubMed ID: 19095723 [No Abstract] [Full Text] [Related]
14. Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases. Bei Y; Yu P; Cretoiu D; Cretoiu SM; Xiao J Adv Exp Med Biol; 2017; 998():71-88. PubMed ID: 28936733 [TBL] [Abstract][Full Text] [Related]
15. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease. Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020 [TBL] [Abstract][Full Text] [Related]
16. Biomarker-based risk prediction in the community. AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304 [TBL] [Abstract][Full Text] [Related]
17. Special report: C-reactive protein for risk stratification in coronary heart disease screening. TEC Bull (Online); 2002 Nov; 19(3):31-7. PubMed ID: 12839025 [No Abstract] [Full Text] [Related]
18. Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis. McGranaghan P; Saxena A; Rubens M; Radenkovic J; Bach D; Schleußner L; Pieske B; Edelmann F; Trippel TD Biomarkers; 2020 Mar; 25(2):101-111. PubMed ID: 31928240 [No Abstract] [Full Text] [Related]
19. Biomarkers: A Challenging Conundrum in Cardiovascular Disease. Libby P; King K Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2491-5. PubMed ID: 26543097 [TBL] [Abstract][Full Text] [Related]
20. C-reactive protein for the prediction of cardiovascular risk: ready for prime-time? Hackam DG; Shumak SL CMAJ; 2004 May; 170(10):1563-5. PubMed ID: 15136550 [No Abstract] [Full Text] [Related] [Next] [New Search]